MICROWAVE DEVICE FOR MYOCARDIAL ABLATION

Information

  • Research Project
  • 2223070
  • ApplicationId
    2223070
  • Core Project Number
    R44HL046580
  • Full Project Number
    5R44HL046580-03
  • Serial Number
    46580
  • FOA Number
  • Sub Project Id
  • Project Start Date
    5/15/1991 - 33 years ago
  • Project End Date
    1/31/1999 - 26 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1996 - 28 years ago
  • Budget End Date
    1/31/1999 - 26 years ago
  • Fiscal Year
    1996
  • Support Year
    3
  • Suffix
  • Award Notice Date
    7/24/1996 - 28 years ago

MICROWAVE DEVICE FOR MYOCARDIAL ABLATION

The goal of the proposed program is to develop a device for myocardial ablation using microwave heating and Passive Microwave Radiometry (PMR) for tissue temperature monitoring. The device consists of an applicator, a microprocessor-controlled solid-state microwave energy source at 915 MHz for heating and a PMR device at 4.0 GHz. Using PMR to monitor the temperature of a volume of tissue enables the device to deliver localized heating to tissue under feedback control. The applicator is a novel adaptation of an antenna formed with thin, flexible coaxial cable with a helically wound tip. This configuration is capable of simultaneous heating and temperature monitoring and allows intraoperative ablation or catheter ablation for treatment of cardiac arrhythmias, particularly ventricular tachyarrhythmias. The unique feature of this ablation method is its ability to create reproducible, uniform lesions with selectable depths from 2-3 mm up to several centimeters in less than a minute. Since PMR measures the temperature of an integrated volume of tissue, it is superior to ablation systems employing point source thermocouple measurements. At present, no other technique including DC shock, RF, laser or cryoablation generates such a broad, shallow lesion. PROPOSED COMMERCIAL APPLICATION: The proposed microwave heating method offers physicians a rapid, uniform and controlled technique for myocardial ablation to treat ventricular tachyarrhythmia in those patients who are poor candidates for antiarrhythmic drug treatment. The commercial market for such a device is large. Each year, approximately one million people in the United States die of cardiovascular disease. Of these, several hundred thousand die of sudden death, often the result of ventricular tachyarrhythmia related to myocardial infarction.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    MICROWAVE MEDICAL SYSTEMS, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    ACTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    01720
  • Organization District
    UNITED STATES